John Klecker, PhD retweetledi

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
news.abbvie.com/2025-08-25-Abb…
English
John Klecker, PhD
167 posts

@JohnKlecker
Drug Discovery Scientist | 🎓 '22 PhD - Chemistry Tonge Lab @stonybrooku | 🎓'17 BA - (ACS) Biochemistry & Classics @AugustanaSD | Kinetics, DMPK, & PK/PD



thats postdoc pay bro














